Clinical behaviour of 208 stage II endometrial cancer cases

被引:0
|
作者
Zanagnolo, V [1 ]
Sartori, E [1 ]
Gadducci, A [1 ]
Landoni, F [1 ]
Maggino, T [1 ]
Zola, P [1 ]
机构
[1] Univ Brescia, Dept Obstet & Gynecol, I-25121 Brescia, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two hundred and eight women with stage II disease, who underwent surgery between 1980 and 1995 in 5 different Ob/Gyn department, were retrospectively reviewed. 135 (64%) underwent total abdominal hysterectomy and 73 (36%) radical hysterectomy. 66/111 (59%) of stage IIA and 67/92 (73%) of stage IIB underwent adjuvant radiation therapy. Actuarial survival rate for stage IIA and IIB endometrial cancer patients was 86% and 74% at 5 years, 82% and 68% at 10 years respectively. Survival rate by surgical procedure was 79% in the simple hysterectomy group and 94% in the radical hysterectomy one at 5 years, 74% and 94% respectively at 10 years. The difference did show a trend but it was not statistically significant (P=0.085). Overall survival rate by adjuvant treatment did not show any statistically significant difference between the observation and the adjuvant therapy group.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 50 条
  • [1] What is the clinical significance of stage II endometrial cancer?
    Nelson, D.
    Nizam, A.
    Shih, K. K.
    Shan, W.
    Bustamante, B.
    dos Santos, L.
    Frimer, M.
    Menzin, A. W.
    Sakaris, A.
    Whyte, J. S.
    Goldberg, G. L.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 208 - 209
  • [2] ENDOMETRIAL CANCER STAGE II - 190 CASES WITH DIFFERENT PREOPERATIVE IRRADIATION
    NOREN, H
    GRANBERG, S
    FRIBERG, LG
    GYNECOLOGIC ONCOLOGY, 1991, 41 (01) : 17 - 21
  • [3] Clinical stage II endometrial cancer: Is there a benefit to radical hysterectomy?
    Lennox, G. K.
    Clark, M.
    Zigras, T.
    Rouzbahman, M.
    Han, G.
    Bernardini, M. Q.
    Gien, L. T.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 103 - 103
  • [4] Clinical Factors Important in the Management of Stage II Endometrial Cancer
    Mattson, I.
    McDonald, M.
    Bender, D.
    Mott, S.
    Goodheart, M.
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 221 - 221
  • [5] Oncological outcomes of stage ii endometrial cancer a retrospective analysis of 250 cases
    Ibrahimov, Akbar Akbar
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A229 - A229
  • [6] Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 Cases
    Ozgul, Nejat
    Boyraz, Gokhan
    Salman, Mehmet Coskun
    Gultekin, Murat
    Yuce, Kunter
    Ibrahimov, Akbar
    Erturk, Anil
    Gungorduk, Kemal
    Gulseren, Varol
    Sanci, Muzaffer
    Turkmen, Osman
    Karalok, Alper
    Kimyon, Gunsu
    Turan, Taner
    Ozkan, Nazli Topfedaisi
    Meydanli, Mehmet Mutlu
    Gungor, Tayfun
    Ayik, Hulya
    Simsek, Tayup
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (01) : 161 - 167
  • [7] Clinical behavior of 203 stage II endometrial cancer cases: The impact of primary surgical approach and of adjuvant radiation therapy
    Sartori, E
    Gadducci, A
    Landoni, F
    Lissoni, A
    Maggino, T
    Zola, P
    Zanagnolo, V
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 (06) : 430 - 437
  • [8] Clinical Outcomes Following Adjuvant Management of FIGO Stage II Endometrial Cancer
    Mohammadi, H.
    Abuodeh, Y. A.
    Naghavi, A. O.
    Fernandez, D. C.
    Montejo, M. E.
    Apte, S. M.
    Hoffman, M. S.
    Shahzad, M. M.
    Wenham, R. M.
    Chon, H. S.
    Ahmed, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E651 - E651
  • [9] ENDOMETRIAL CARCINOMA - 128 CASES AT STAGE-I AND STAGE-II
    PANICI, PB
    DIROBERTO, PF
    MARGARITI, PA
    SCAMBIA, G
    BOMPIANI, A
    MANCUSO, S
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1987, 24 (02) : 138 - 144
  • [10] Prevalence of paraaortic lymph node metastasis in presumed clinical stage II endometrial cancer
    Seon, Ki Eun
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eunji
    Kim, Sunghoon
    Kim, Young Tae
    Kim, Sang Wun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A147 - A147